XML 26 R8.htm IDEA: XBRL DOCUMENT v3.22.0.1
Consolidated Statements of Cash Flows - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Operating activities:      
Net income (loss) $ 456 $ (4,099) $ (1,000)
Adjustments to reconcile net loss to net cash provided by operations:      
Impairment of goodwill, long-lived assets and assets held for sale 584 6,546 1,778
Depreciation and amortization 1,330 1,557 1,722
Net change in operating assets and liabilities (1,701) (2,188) (896)
Deferred income taxes—net and uncertain tax positions (120) (696) (985)
Stock-based compensation 119 129 119
Other items 16 100 28
Research and development in process 10 80 0
Net loss (gain) from investments and from sale of business and long lived assets 104 (213) (18)
Net cash provided by operating activities 798 1,216 748
Investing activities:      
Beneficial interest collected in exchange for securitized trade receivables 1,648 1,405 1,487
Proceeds from sale of business and long lived assets 311 67 343
Purchases of property, plant and equipment (562) (578) (525)
Purchases of investments and other assets (47) (55) (8)
Proceeds from sale of investments 172 12 2
Other investing activities 1 12 56
Net cash provided by investing activities 1,523 863 1,355
Financing activities:      
Repayment of senior notes and loans and other long-term liabilities (6,649) (1,871) (3,944)
Proceeds from senior notes, net of issuance costs 4,974 0 2,083
Proceeds from short term debt 700 550 500
Repayment of short term debt (700) (559) (502)
Redemption of convertible debentures (491) 0 0
Other financing activities (6) (5) (11)
Tax withholding payments made on shares and dividends 0 0 (52)
Net cash used in financing activities (2,172) (1,885) (1,926)
Translation adjustment on cash and cash equivalents (128) 8 16
Net change in cash, cash equivalents and restricted cash 21 202 193
Balance of cash, cash equivalents and restricted cash at beginning of year 2,177 1,975 1,782
Balance of cash, cash equivalents and restricted cash at end of year 2,198 2,177 1,975
Reconciliation of cash, cash equivalents and restricted cash reported in the consolidated balance sheets:      
Cash and cash equivalents 2,165 2,177 1,975
Restricted cash included in other current assets 33 0 0
Total cash, cash equivalents and restricted cash shown in the statement of cash flows 2,198 2,177 1,975
Non-cash financing and investing activities:      
Beneficial interest obtained in exchange for securitized trade receivables 1,635 1,397 1,511
Cash paid during the year for:      
Interest 913 846 840
Income taxes, net of refunds 495 709 552
Net change in operating assets and liabilities:      
Other current assets (2,271) (1,473) (1,416)
Trade payables, accrued expenses, employee-related obligations and other liabilities 764 (463) 643
Trade receivables net of sales reserves and allowances (574) (293) (394)
Inventories 380 41 271
Net Change In Items Comprising Supplemental Disclosure Of Cash Flow Information $ (1,701) $ (2,188) $ (896)